Skip to content

CYTO

Altamira Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · BM

$0.30
+0.00%
Ask drillr

Margins

Gross margin
EBITDA margin
EBIT margin
Net margin
FCF margin
398.5%
Return on equity
-117.2%
Return on assets
-360.2%
Return on invested capital
0.00x
Asset turnover
-$14.0M
Cash from operations
$0.12
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2023